Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2024-10-20
2024-10-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Appetite Responses to Cereal Products
NCT05855837
Beta-glucan, Product Claims and Satiety
NCT04740112
The Effect of Oat Based Breakfast Cereals on Satiety and Food Intake.
NCT01666561
The Effect of Oat Based Breakfast Cereals on Satiety and Food Intake
NCT01666574
Oat Breakfast Satiety Study
NCT01372683
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breakfast Bar
Packaged breakfast bar available in retail stores
Breakfast Bar
Packaged breakfast bar product available in retail stores
Control
No intervention (i.e., no food provided)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breakfast Bar
Packaged breakfast bar product available in retail stores
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Habitual snack bar consumers (at least several times per month)
* Body mass index 18.5-29.9 kg/m2 (based on self-reported weight and height)
* Understand and willing to follow the study procedures
* Willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial
* Willing to abstain from strenuous exercise, consuming alcoholic drinks 24 hours before the test day
* Willing to provide informed consent to participate in the study
Exclusion Criteria
* Known food allergies, sensitivities, or intolerance to any food or food ingredients
* Participating in another clinical trial for food, investigational drug, nutritional supplement, or lifestyle modification
* Taking medications that affect appetite, metabolism or blood pressure
* Presence of acute diseases or infection
* Presence or history of chronic diseases
* Diagnosed with an eating disorder
* Restraint eaters as determined by a score \>4 from the Dutch Eating Behavior Questionnaire
* Lost or gained 5 or more pounds in the past 3-months
* On a weight loss diet or undergoing intermittent fasting
* COVID-19 infection within the past 3 months
* Subjects who do not eat bar products
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General Mills
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Remote
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
597
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.